Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study-Reference-Cited by-同舟云学术

Efficacy and Safety of a Fixed-Dose Combination of Vildagliptin and Pioglitazone in Indian Patients With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Comparative, Phase III Study

Published:2023-09-01 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Erande Suhas,Mukhopadhyay Jotideb,Dange Amol,Deogaonkar Anushka,Birla Ashish,Doshi Chetan,Revankar Santosh,B Sridhar S,Kumar Neeraj,Kadam Pramod V

Publisher

Springer Science and Business Media LLC

Subject

Aerospace Engineering

Reference15 articles.

1. Epidemiology of type 2 diabetes in India;Pradeepa R;Indian J Ophthalmol,2021

2. Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol;Yeu RQ;BMJ Open,2020

3. Efficacy and safety of vildagliptin/pioglitazone combination therapy in Korean patients with diabetes;Kim SW;World J Diabetes,2010

4. Insights from VERIFY: early combination therapy provides better glycaemic durability than a stepwise approach in newly diagnosed type 2 diabetes;Matthews D;Diabetes Ther,2020

5. Histological course of nonalcoholic fatty liver disease in Japanese patients: tight glycemic control, rather than weight reduction, ameliorates liver fibrosis;Hamaguchi E;Diabetes Care,2010

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Affordable Combinations in Type 2 Diabetes Care: Exploring the Cost-Effective Potential of Glipizide + Metformin and Glimepiride + Metformin + Pioglitazone;Cureus;2024-05-07